Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

NCT: NCT06608823 · RECRUITING

NCT IDNCT06608823
StatusRECRUITING
Start Date2025-06-18
Completion2036-02

Brief Summary

To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for treatment of subjects with clinically significant native aortic regurgitation (AR)

Frequently Asked Questions

What is ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™?

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ is a clinical trial registered under NCT06608823. Current status: RECRUITING.

What is the status of NCT06608823?

The current status of NCT06608823 (ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™) is: RECRUITING.

When did ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ start?

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ started on 2025-06-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑